EFFECTIVENESS OF YASHTIMADHU CHURNA, AMALAKI RASAYANA AND PHALATRIKADI KWATH IN HEPATOSTEATOSIS: A CASE REPORT

Hepatic steatosis is defined as the accumulation of intrahepatic fat of at least 5% of liver weight, which may lead to metabolic dysfunction and inflammation in the liver. It is a common condition in 7% to 30% of people and gets worse over time into liver fibrosis, cirrhosis, and hepatocellular carcinoma. Modern science illustrates that there is no specific treatment protocol for fatty liver disease (FLD) except a healthy diet and exercise. In this case report, an individual was diagnosed with hepatosteatosis, having symptoms- pain in the abdomen with heartburn, burning in the throat, excessive thirst, belching, lassitude, constipation, nausea, and a yellowish appearance in the eyes. Fibroscan shows 77% of fat deposition with fibrosis (Grade F1). Based on the cardinal features of Udarashula, Chardi, and Peetanetra, the patient was assigned as a case of Parinam Shula and treated according to the line of management of Shula Chikitsa. After 3 months of drug intervention, there is a significant reduction in symptoms. Fibroscan shows a significant reduction in fat deposition (77% to 24%) with changes in fibrosis grading (from F1 to F0).